Tech Company Financing Transactions
Axcella Health Funding Round
Axcella Health secured a $42.5 million funding round on 2/24/2016. Backers included Nestlé Health Science.
Transaction Overview
Company Name
Announced On
2/24/2016
Transaction Type
Venture Equity
Amount
$42,500,000
Round
Undisclosed
Investors
Nestlé Health Science (Greg Behar)
Proceeds Purpose
The proceeds from this financing will help to fund the ongoing rapid transformation of the company from a unique and revolutionary platform to late stage clinical candidates in several disease indications.
Company Information
Company Status
Publicly-held
Industry
Consumer
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Overview
Axcella Health (Nasdaq: AXLA) is a pioneer in developing transformative medicines for patients with diseases in which disrupted amino acid biology plays a central role.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Connelly
Chief Financial Officer
Thomas Leggett
Chief Information Officer
David Berry
Chief Medical Officer
Manu Chakravarthy
VP - Bus. Development
Ivana Magovcevic-Liebisch
VP - R & D
Michael Hamill
VP - R & D
Tony Tramontin
Browse more venture capital transactions:
Prev: 2/24/2016: Routific venture capital transaction
Next: 2/24/2016: Quantifind venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs